BioMed Research International

Clinical Study

A Flow Cytometric Analysis of Vitreous Inflammatory Cells in Patients with Proliferative Diabetic Retinopathy

Table 4

Comparison of blood non-contaminated (nPDR) and contaminated (cPDR) vitreous samples of patients with PDR (median, minimum–maximum; Mann Whitney test).


	Vitreous
	nPDR ()	cPDR ()	P value

CD45 ()	401.0 (181.0–1644.0)	938.0 (273.0–4926.0)	0.029
Ly (%)	3.3 (0.4–55.5)	14.7 (0.6–89.6)	0.048
CD14all (%)	64.1 (34.0–79.3)	60.5 (5.3–87.7)	0.546
CD19 (%)	0 (0-0)	0 (0–9.7)	0.211
CD3 (%)	57.5 (0–100.0)	88 (0–100.0)	0.012
CD3/CD19	84.0 (47.7–100.0)	86.9 (14.1–100.0)	0.723
CD4 (%)	64.0 (0–100.0)	77.5 (0–100.0)	0.065
CD8 (%)	0 (0–26.0)	15.9 (0–66.7)	0.098
CD4/CD8	3.9 (2.2–100.0)	4.6 (0.5–100.0)	0.724

Legend: nPDR: PDR patients with blood non-contaminated vitreous; cPDR: PDR patients with blood contaminated vitreous; CD45+: leukocytes; Ly: lymphocytes; CD14+: macrophages; CD19+: B lymphocytes; CD3+: T lymphocytes; CD4+: T helper lymphocytes; CD8+: T cytotoxic lymphocytes.